In oncology, prior authorization is a critical step in ensuring patients receive timely, life-saving care. Given the high cost and complexity of treatments such as chemotherapy, radiation therapy, and specialty drugs, securing authorization is often seen as a major milestone. 

But for many oncology practices, approval does not guarantee accurate reimbursement. 

A growing number of claims are being approved upfront but paid incorrectly on the back end. This disconnect is creating significant financial pressure for oncology groups that are already navigating tight margins and complex payer requirements. 

 

The “Approved but Underpaid” Problem in Oncology 

Oncology practices frequently encounter situations where treatments are authorized but reimbursed at lower-than-expected rates. 

This can happen for several reasons: 

  • Payers may approve a regimen but apply different reimbursement logic at adjudication 
  • Drug pricing and units may be interpreted differently than expected 
  • Contract terms for high-cost therapies may not align with authorization details 

Because oncology treatments often involve expensive drugs and multi-step care plans, even small discrepancies can result in substantial revenue loss. 

Without a clear way to connect authorization approvals to final payment, these underpayments can easily go unnoticed. 

 

Disconnect Between Clinical and Billing Workflows 

Oncology care is highly coordinated, but revenue cycle workflows are not always aligned in the same way. 

Clinical teams focus on obtaining authorization for specific regimens, doses, and treatment schedules. Billing teams must translate those approvals into accurate coding, charge capture, and payer-compliant claims. 

When these workflows are disconnected, issues arise: 

  • Authorization details may not fully match how services are delivered or billed 
  • Changes in treatment plans may not be reflected in updated authorizations 
  • Documentation may lack the specificity needed to support reimbursement 

In oncology, where treatment plans evolve and payer rules are nuanced, even minor misalignment can lead to underpayment or denials. 

 

Tracking Authorization Across the Oncology Revenue Cycle 

Authorization in oncology is not a one-time event. It must be continuously tracked and validated throughout the patient journey. 

From initial consult and treatment planning to drug administration and follow-up care, practices need visibility into: 

  • Authorized drug regimens and allowable substitutions 
  • Approved units, frequency, and duration of treatment 
  • Authorization validity periods tied to ongoing care 

When this information is not accessible at every stage of the revenue cycle, it becomes difficult to ensure that what was authorized matches what is billed and paid. 

Many oncology practices still rely on manual tracking or disconnected systems, which increases the risk of missed details and lost revenue. 

 

Operational Alignment Strategies for Oncology Practices 

To close the gap between authorization and payment, oncology practices need stronger alignment across teams and workflows. 

Key strategies include: 

  • Standardizing documentation across clinical and billing teams to ensure consistency in treatment plans, drug usage, and coding 
  • Coordinating authorization updates when treatment plans change, especially for dose adjustments or regimen modifications 
  • Implementing pre-bill validation processes to confirm that services align with authorization details 
  • Establishing feedback loops to identify payer-specific patterns in underpayment for oncology services 

These steps help ensure that the complexity of oncology care is accurately reflected in both documentation and reimbursement. 

 

The Role of Integrated RCM Platforms in Oncology 

Given the complexity of oncology billing, disconnected systems create unnecessary risk. 

Integrated revenue cycle platforms are essential for bringing together clinical, authorization, and billing data into a single, actionable workflow. 

With ImagineSoftware’s ImagineOne®, oncology practices can: 

  • Track authorization details alongside treatment and billing workflows 
  • Align clinical documentation with payer requirements for high-cost therapies 
  • Identify discrepancies between authorized and billed services before claims are submitted 
  • Gain insight into payer behavior for oncology-specific reimbursement patterns 

This level of integration is especially valuable in oncology, where precision and accuracy directly impact both patient care and financial performance. 

 

Turning Authorization into Accurate Reimbursement 

For oncology practices, authorization is only the beginning. 

Ensuring that approved treatments are reimbursed correctly requires continuous alignment across the entire revenue cycle. By connecting clinical intent, authorization detail, and billing execution, practices can reduce revenue leakage and improve financial stability. 

In an environment where every dollar matters, closing this gap is not optional. It is essential. 

 

Ready to Strengthen Your Oncology Revenue Cycle? 

If your oncology practice is seeing authorized treatments that are still underpaid, it is time to take a closer look at your processes. 

Schedule a demo with our team today to see how ImagineOne can help you align authorization workflows, improve documentation accuracy, and ensure that approved oncology care is reimbursed as expected.